Status:
UNKNOWN
Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction
Lead Sponsor:
Assiut University
Conditions:
Androgenetic Alopecia
Eligibility:
MALE
18-60 years
Phase:
PHASE4
Brief Summary
Androgenetic alopecia is the most common type of alopecia in both men and women. About 80 % of Caucasian men and 40-50 % of Caucasian women are affected by androgenetic alopecia. The psychological imp...
Detailed Description
Currently, two medications are Food and Drug Administration approved in the treatment of Androgenetic alopecia which are minoxidil, and finasteride. Both medications must be taken indefinitely for ben...
Eligibility Criteria
Inclusion
- male patients with androgenetic alopecia between 18 years and 60 years
Exclusion
- Patients with Non-androgenetic causes of hair loss.
- Female patients with androgenetic alopecia.
- Patients who received anti-hair loss treatment within the past six months.
- Patients with history of bleeding disorders or on anticoagulant therapy.
- Patients with history of chronic liver disease, cancer or connective tissue disorders.
- Patients with current scalp infection.
Key Trial Info
Start Date :
January 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03388840
Start Date
January 15 2018
End Date
March 1 2021
Last Update
September 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospitals
Asyut, Egypt